genia tagger: 42('and', 186)
('globulin', 2)
('saa', 15)
('alc', 10)
('surface', 1)
('1980s', 2)
('arc', 16)
('anti-thymocyte', 2)
('pr', 93)
('gpi', 3)
('\\;', 113)
('hemoglobin', 2)
('5', 78)
('g-csf', 2)
('7', 70)
('between', 10)
('lymphocytes', 1)
('-anchored', 1)
('red', 59)
('\\)', 220)
('glycosylphosphatidylinositol', 1)
('chromosomes', 1)
('hsct', 73)
('clone', 2)
('1970s', 2)
('pnh', 2)
('ng\\/ml\\.', 4)
('blood', 12)
('gpi-', 2)
('4', 104)
('atg', 48)
('\xe2\x80\x93', 16)
('15', 6)
('cells', 2)
('proteins', 1)
('monosomy', 12)
('ist', 129)
('\\(', 208)
('were', 93)
('neutrophils', 2)
('atgam', 2)
('trough', 2)


spacy + metamap: 341('mg\\/m2', 4)
('optimal', 2)
('multicenter study', 4)
('reticulocyte count', 2)
('partial', 10)
('absolute', 4)
('transplants', 2)
('german', 2)
('administration', 2)
('lack', 7)
('pharmacia', 2)
('legal guardian', 2)
('years', 27)
('four', 7)
('course', 13)
('50\\%', 2)
('completed', 6)
('fungal infections', 4)
('statistical', 4)
('japan', 6)
('alternative', 10)
('cyclosporin', 4)
('children', 63)
('60\\%', 6)
('statistical methods', 2)
('current', 2)
('death', 21)
('based', 17)
('conclusions', 1)
('immunosuppressive therapy', 3)
('proportion', 10)
('young', 4)
('late', 13)
('ham test', 1)
('parents', 1)
('treatment', 23)
('sepsis', 4)
('lymphocytes', 1)
('31', 6)
('risk factors', 2)
('tests', 6)
('good', 1)
('assay', 2)
('dysplastic', 2)
('combination', 2)
('means', 2)
('survival', 40)
('clonal', 8)
('overall', 27)
('multi', 8)
('greater than', 1)
('early', 14)
('test', 14)
('therapy', 8)
('protocol entry', 1)
('new', 2)
('dose', 12)
('1970s', 2)
('day', 22)
('association', 2)
('matched', 35)
('wa', 124)
('entire', 5)
('evolution', 21)
('\\/ul', 44)
('standardization', 2)
('level', 3)
('partial response', 1)
('bone marrow', 6)
('prophylaxis', 4)
('median', 14)
('less than', 17)
('summary', 2)
('large', 6)
('discrete', 4)
('fungal infection', 16)
('estimates', 2)
('superiority', 2)
('contrast', 2)
('response rate', 39)
('regimens', 4)
('neutrophils', 2)
('higher', 6)
('disorder', 2)
('aspiration', 1)
('two', 11)
('view', 3)
('overall response', 5)
('slow', 2)
('small', 4)
('methods', 5)
('treatment regimen', 2)
('cyclosporine', 4)
('national', 2)
('skin test', 2)
('bacterial septicemia', 4)
('related', 6)
('sex', 2)
('past', 2)
('rate', 45)
('characteristics', 8)
('result', 7)
('year', 39)
('patient', 176)
('institutes', 1)
('baseline', 40)
('paroxysmal nocturnal hemoglobinuria', 1)
('hla', 9)
('blood products', 4)
('recently', 4)
('90\\%', 9)
('alc', 10)
('subsequent', 4)
('4c', 4)
('recommendation', 2)
('hematologic', 6)
('research', 1)
('nih clinical center', 2)
('p-value', 2)
('absolute lymphocyte count', 2)
('sequential', 1)
('health', 1)
('hsct', 73)
('f-test', 2)
('consecutive', 3)
('risk group', 2)
('transplant', 13)
('1d', 4)
('independence', 5)
('risks', 2)
('myelodysplasia', 10)
('pr', 93)
('study design', 3)
('pediatrics', 1)
('parent', 2)
('red blood cells', 1)
('complete response', 1)
('supportive care', 10)
('standard', 6)
('five', 4)
('pancytopenia', 1)
('host', 2)
('peripheral blood count', 2)
('conditioning', 2)
('groups', 6)
('bone marrow cellularity', 1)
('group', 22)
('november', 1)
('mmf', 2)
('table', 2)
('clonal evolution', 6)
('earlier', 2)
('institutional review board', 1)
('taper', 4)
('institute', 2)
('study', 12)
('months', 50)
('days', 14)
('reports', 2)
('transplantation', 9)
('plus', 2)
('pediatric', 8)
('retrospective study', 2)
('variance', 2)
('one', 40)
('follow up', 2)
('changes', 2)
('numerical', 2)
('first', 12)
('presence', 1)
('standard deviation', 2)
('ages', 8)
('mitomycin c', 1)
('cyclophosphamide', 2)
('vitro', 1)
('mg\\/kg\\/day', 2)
('satisfaction', 1)
('conjunction', 2)
('reported', 4)
('lung', 1)
('65', 10)
('68', 6)
('cr', 24)
('total', 22)
('early death', 2)
('size', 3)
('long term survival', 12)
('better', 4)
('horse', 2)
('statistics', 2)
('basis', 2)
('probabilities', 2)
('40\\%', 2)
('initial', 13)
('1990s', 10)
('three', 7)
('approximately', 2)
('mark', 1)
('severe aplastic anemia', 2)
('clinical', 4)
('anc', 40)
('reduction', 2)
('criteria', 6)
('haploidentical', 4)
('retrospective studies', 4)
('minor', 1)
('clinical research', 1)
('only', 2)
('3 months', 11)
('fanconi anemia', 1)
('retrospective', 9)
('morphologic diagnosis', 4)
('month', 56)
('transfusion', 5)
('company', 2)
('continuous', 2)
('prospective studies', 4)
('infusion', 2)
('time periods', 2)
('immunosuppressive', 5)
('pnh', 2)
('proportional', 2)
('adult', 6)
('rabbit', 6)
('mich', 2)
('unrelated donor', 2)
('cases', 5)
('highest', 1)
('institution', 6)
('protocols', 4)
('population', 4)
('discussion', 2)
('1980s', 2)
('regimen', 9)
('survival rate', 2)
('hematologic response', 6)
('advance', 2)
('characteristic', 10)
('enrollment', 2)
('package', 2)
('appearance', 2)
('second', 4)
('glycosylphosphatidylinositol', 1)
('patients', 134)
('absence', 1)
('nine', 5)
('bone marrow biopsy', 3)
('following', 24)
('outcome', 17)
('similar', 6)
('informed consent', 1)
('red cells', 1)
('heart', 1)
('adults', 2)
('factor', 4)
('deaths', 16)
('hemoglobin', 2)
('december', 1)
('saa', 15)
('doses', 2)
('assent', 1)
('purposes', 1)
('studies', 10)
('monosomy', 12)
('sample', 6)
('sibling', 35)
('mg\\/kg\\/d', 8)
('30\\%', 1)
('experience', 2)
('follow-up', 6)
('\\/kg', 8)
('long term', 14)
('upjohn', 2)
('80\\%', 11)
('complete', 11)
('cohort', 23)
('different', 7)
('immunosuppression', 2)
('present', 2)
('relapse', 41)
('\\/day', 2)
('grant', 1)
('divided', 2)
('cumulative', 10)
('csa', 21)
('detail', 2)
('centers', 2)
('sirolimus', 4)
('high', 11)
('low', 39)
('objective', 1)
('donor', 21)
('several', 6)
('events', 5)
('failure', 4)
('european', 4)
('week', 2)
('age group', 16)
('europe', 6)
('repeat', 8)
('chromosomes', 1)
('prednisone', 2)
('cytogenetic abnormalities', 4)
('separate', 4)
('models', 2)
('serum sickness', 4)
('clone', 2)
('incidence', 16)
('effect', 2)
('hazard', 2)
('difference', 6)
('levels', 2)
('mouth', 2)
('blood', 12)
('entry', 3)
('date', 2)
('complications', 8)
('marrow', 10)
('data', 2)
('response', 62)
('exposure', 1)
('kg', 10)
('center', 10)
('confidence intervals', 2)
('cytogenetics', 3)
('4b', 4)
('age', 55)
('10 days', 2)
('clinical center', 3)
('analysis', 17)
('age distribution', 2)
('more', 13)
('severe', 3)
('status', 4)
('time', 24)
('research center', 1)
('model', 2)
('4a', 4)
('oral', 2)
('atgam', 2)
('trough', 2)


total: 366('partial', 10)
('lack', 7)
('alc', 10)
('month', 56)
('four', 7)
('children', 63)
('immunosuppressive therapy', 3)
('young', 4)
('present', 2)
('risk factors', 2)
('assay', 2)
('7', 70)
('nih clinical center', 2)
('trough', 2)
('difference', 6)
('entire', 5)
('level', 3)
('cyclosporine', 4)
('large', 6)
('discrete', 4)
('red', 59)
('standard deviation', 2)
('overall response', 5)
('estimates', 2)
('past', 2)
('rate', 45)
('blood products', 4)
('hematologic', 6)
('centers', 2)
('current', 2)
('sequential', 1)
('hsct', 73)
('new', 2)
('contrast', 2)
('pediatrics', 1)
('complete response', 1)
('reported', 4)
('peripheral blood count', 2)
('groups', 6)
('november', 1)
('institutional review board', 1)
('taper', 4)
('institute', 2)
('study', 12)
('monosomy', 12)
('experience', 2)
('pediatric', 8)
('studies', 10)
('regimens', 4)
('total', 22)
('transplant', 13)
('probabilities', 2)
('two', 11)
('criteria', 6)
('minor', 1)
('clinical research', 1)
('3 months', 11)
('advance', 2)
('detail', 2)
('company', 2)
('infusion', 2)
('adult', 6)
('rabbit', 6)
('cases', 5)
('1980s', 2)
('nine', 5)
('following', 24)
('heart', 1)
('hemoglobin', 2)
('december', 1)
('assent', 1)
('purposes', 1)
('sample', 6)
('anti-thymocyte', 2)
('upjohn', 2)
('absolute', 4)
('discussion', 2)
('reticulocyte count', 2)
('csa', 21)
('optimal', 2)
('fungal infections', 4)
('serum sickness', 4)
('clone', 2)
('earlier', 2)
('hazard', 2)
('blood', 12)
('date', 2)
('marrow', 10)
('data', 2)
('response', 62)
('hematologic response', 6)
('clinical center', 3)
('divided', 2)
('transplants', 2)
('protocol entry', 1)
('years', 27)
('course', 13)
('statistical', 4)
('japan', 6)
('p-value', 2)
('group', 22)
('late', 13)
('absence', 1)
('good', 1)
('combination', 2)
('therapy', 8)
('day', 22)
('association', 2)
('matched', 35)
('bone marrow', 6)
('prophylaxis', 4)
('proteins', 1)
('response rate', 39)
('clonal evolution', 6)
('higher', 6)
('status', 4)
('skin test', 2)
('bacterial septicemia', 4)
('related', 6)
('year', 39)
('hla', 9)
('research', 1)
('health', 1)
('dysplastic', 2)
('independence', 5)
('numerical', 2)
('standard', 6)
('small', 4)
('conditioning', 2)
('bone marrow cellularity', 1)
('mmf', 2)
('atg', 48)
('days', 14)
('ist', 129)
('1970s', 2)
('first', 12)
('vitro', 1)
('one', 40)
('size', 3)
('horse', 2)
('gpi', 3)
('approximately', 2)
('severe aplastic anemia', 2)
('1d', 4)
('retrospective studies', 4)
('bone marrow biopsy', 3)
('completed', 6)
('continuous', 2)
('pnh', 2)
('institution', 6)
('population', 4)
('15', 6)
('aspiration', 1)
('cytogenetics', 3)
('second', 4)
('patients', 134)
('risks', 2)
('were', 93)
('outcome', 17)
('red cells', 1)
('and', 186)
('anc', 40)
('globulin', 2)
('saa', 15)
('ages', 8)
('30\\%', 1)
('time periods', 2)
('complete', 11)
('relapse', 41)
('proportional', 2)
('high', 11)
('objective', 1)
('donor', 21)
('age group', 16)
('chromosomes', 1)
('prednisone', 2)
('incidence', 16)
('ng\\/ml\\.', 4)
('mouth', 2)
('mitomycin c', 1)
('kg', 10)
('informed consent', 1)
('age distribution', 2)
('research center', 1)
('mg\\/m2', 4)
('multicenter study', 4)
('german', 2)
('legal guardian', 2)
('paroxysmal nocturnal hemoglobinuria', 1)
('cyclosporin', 4)
('slow', 2)
('based', 17)
('retrospective study', 2)
('proportion', 10)
('ham test', 1)
('factor', 4)
('mg\\/kg\\/d', 8)
('means', 2)
('overall', 27)
('greater than', 1)
('conjunction', 2)
('evolution', 21)
('median', 14)
('summary', 2)
('fungal infection', 16)
('view', 3)
('treatment regimen', 2)
('national', 2)
('sex', 2)
('arc', 16)
('result', 7)
('institutes', 1)
('parent', 2)
('subsequent', 4)
('between', 10)
('consecutive', 3)
('europe', 6)
('recently', 4)
('wa', 124)
('transplantation', 9)
('variance', 2)
('sepsis', 4)
('satisfaction', 1)
('65', 10)
('68', 6)
('table', 2)
('early death', 2)
('glycosylphosphatidylinositol', 1)
('better', 4)
('basis', 2)
('40\\%', 2)
('three', 7)
('mark', 1)
('reduction', 2)
('treatment', 23)
('cytogenetic abnormalities', 4)
('retrospective', 9)
('morphologic diagnosis', 4)
('transfusion', 5)
('unrelated donor', 2)
('protocols', 4)
('multi', 8)
('enrollment', 2)
('appearance', 2)
('10 days', 2)
('31', 6)
('characteristics', 8)
('surface', 1)
('reports', 2)
('long term', 14)
('80\\%', 11)
('cohort', 23)
('different', 7)
('immunosuppression', 2)
('baseline', 40)
('grant', 1)
('cumulative', 10)
('administration', 2)
('sirolimus', 4)
('several', 6)
('events', 5)
('european', 4)
('week', 2)
('absolute lymphocyte count', 2)
('study design', 3)
('effect', 2)
('levels', 2)
('cr', 24)
('\\/day', 2)
('confidence intervals', 2)
('changes', 2)
('analysis', 17)
('severe', 3)
('entry', 3)
('model', 2)
('pharmacia', 2)
('dose', 12)
('50\\%', 2)
('alternative', 10)
('60\\%', 6)
('statistical methods', 2)
('death', 21)
('conclusions', 1)
('\\;', 113)
('parents', 1)
('4', 104)
('lymphocytes', 1)
('\\(', 208)
('\\)', 220)
('tests', 6)
('survival', 40)
('clonal', 8)
('early', 14)
('five', 4)
('\\/ul', 44)
('standardization', 2)
('partial response', 1)
('less than', 17)
('immunosuppressive', 5)
('superiority', 2)
('neutrophils', 2)
('disorder', 2)
('methods', 5)
('recommendation', 2)
('g-csf', 2)
('risk group', 2)
('myelodysplasia', 10)
('pr', 93)
('patient', 176)
('90\\%', 9)
('red blood cells', 1)
('pancytopenia', 1)
('host', 2)
('gpi-', 2)
('package', 2)
('months', 50)
('plus', 2)
('presence', 1)
('cyclophosphamide', 2)
('mg\\/kg\\/day', 2)
('lung', 1)
('1990s', 10)
('long term survival', 12)
('statistics', 2)
('initial', 13)
('survival rate', 2)
('clinical', 4)
('low', 39)
('exposure', 1)
('only', 2)
('fanconi anemia', 1)
('failure', 4)
('mich', 2)
('highest', 1)
('regimen', 9)
('characteristic', 10)
('cells', 2)
('complications', 8)
('more', 13)
('similar', 6)
('follow up', 2)
('adults', 2)
('deaths', 16)
('doses', 2)
('sibling', 35)
('follow-up', 6)
('prospective studies', 4)
('\\/kg', 8)
('5', 78)
('test', 14)
('-anchored', 1)
('repeat', 8)
('separate', 4)
('models', 2)
('f-test', 2)
('center', 10)
('supportive care', 10)
('haploidentical', 4)
('\xe2\x80\x93', 16)
('oral', 2)
('age', 55)
('atgam', 2)
('time', 24)
('4b', 4)
('4c', 4)
('4a', 4)
